Patentometric analysis as a subsid to the management of technological innovation: a case study in radiopharmaceuticals for cancer

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
UNIV FEDERAL SANTA CATARINA
Autores
CHAVES, Henrique Koch
SILVA, Julia Maria Brandao da
SILVEIRA, Carla Cristina de Freitas da
MAGALHAES, Jorge Lima de
Citação
ENCONTROS BIBLI-REVISTA ELETRONICA DE BIBLIOTECONOMIA E CIENCIA DA INFORMACAO, v.28, article ID e93547, 21p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: Prospect the evolution of patent applications onIdentify, extract, process data, organize and make available technological information in the form of graphical interfaces described in oncology patents containing the radioisotopes gallium-68 (Ga-68), copper-64 (Cu-64) and zirconium-89 ((89)Z) in order to understand the development of science and technology in the area. Method: The ORBIT Intelligence (R) platform from the company QUESTEL (R) was used to identify, extract, process the data, organize and make available the technological information in the form of graphical interfaces, analysis of the filed patents in force in the last 20 years in the main patent offices in the world. Result: For gallium-68, copper-64 and zirconium-89, respectively, 36, 18 and 10 families of patents containing the search terms described in the methodology were identified. In both cases, China stands out in the number of filed patent applications, depositing 61% of the total analyzed. It was also observed that many of the analyzed documents were deposited by universities, reinforcing the concept of company-university partnership. The results obtained point out that the area of this study continues to grow and the understanding of the information present in the patent documents makes it possible to reflect on spaces to intensify the development of innovations in the oncology area. Conclusions: The results obtained demonstrate the relevance of information for the management of a country's technological development, which can serve as an efficient method to analyze, compare and monitor research and development activities in cancer and also support the planning processes organizations, as well as supporting public and private health policies.
Palavras-chave
Patent, Neoplasm, Diagnostic Imaging, Radiopharmaceuticals, Diffusion of Innovation
URI
https://observatorio.fm.usp.br/handle/OPI/58849
Referências
  1. Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284
  2. Alberts D, 2011, INFORM RETRIEVAL SER, V29, P3, DOI 10.1007/978-3-642-19231-9_1
  3. ALBUQUERQUE E. DA M., 2000, Revista de Economia Contemporanea, Rio de Janeiro, V4, P85
  4. AMADEI J. R. P, 2009, Ciencia da Informacao, Brasilia, V38, P9
  5. Binns R, 1998, PHARM SCI TECHNOL TO, V1, P95, DOI 10.1016/S1461-5347(98)00033-9
  6. BLASI C. G. D, 2005, A propriedade industrial: os sistemas de marcas, patentes e desenhos industriais analisados a partir da Lei n. 9.279, de 14 de maio de 1996
  7. BLINNIKOV V. I., 1984, World Patent Information, V6, P63
  8. CARPENTER A. M, 1978, Knowledge Organization, V5, P30, DOI [10.5771/0943-7444-1978-1-30.pdf, DOI 10.5771/0943-7444-1978-1-30.PDF]
  9. Chen YM, 2017, ONCOTARGET, V8, P64417, DOI 10.18632/oncotarget.16295
  10. CONSELHO NACIONAL DE SAUDE (Brasil) (CNEN), RMB e a Producao de Radiofarmacos
  11. CONSELHO NACIONAL DE SAUDE (Brasil) (CNEN), 2021, CNS recomenda ao governo investimento de R$ 89,7 milhoes para que SUS continue producao de radiofarmacos ate o final do ano
  12. D'hondt E, 2014, INFORM RETRIEVAL, V17, P520, DOI 10.1007/s10791-014-9239-6
  13. GERMERAAD P., 2017, CIMS Innovation Management Report, P7
  14. GLOBAL CANCER OBSERVATORY, 2020, Cancer today
  15. Grabowski H, 2002, J INT ECON LAW, V5, P849, DOI 10.1093/jiel/5.4.849
  16. GUERREIRO E. S., 2018, Cadernos de Prospeccao, Salvador, V11, P26
  17. Hanney SR, 2015, HEALTH RES POLICY SY, V13, DOI [10.1186/1478-4505-13-1, 10.1186/s12961-015-0006-y]
  18. Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599
  19. IHEALTHCAREANALYST I, 2023, Global Radiopharmaceuticals Market $537 Million by 2029
  20. INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL (INPI), 2023, Classificacao de patentes-Portugues (Brasil)
  21. INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL (INPI), 2020, Patentes
  22. INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL (INPI), 2015, Bases de patentes online
  23. INSTITUTO NACIONAL DE CANCER (Brasil) (INCA), 2023, Estimativa
  24. Kowalsky R., 2004, Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine, V2nd
  25. MAGALHAES J. L. DE., 2018, Ciencia da Informacao, Rio de Janeiro, V13
  26. Meguro K, 2019, WORLD PAT INF, V57, P70, DOI 10.1016/j.wpi.2019.03.008
  27. MORDOR INTELLIGENCE, 2022, China Relatorio de mercado de imagens nucleares | Tamanho, participacao, crescimento e tendencias (2023-28)
  28. NANAYAKKARA D., 2013, Austral -Asian Journal of Cancer, V12, P135
  29. Oliveira Rita, 2006, Rev. Bras. Cienc. Farm., V42, P151, DOI 10.1590/S1516-93322006000200002
  30. Perini EA, 2019, CURR RADIOPHARM, V12, P187, DOI 10.2174/1874471012666190328164253
  31. SAHA G, 2018, Fundamentals of Nuclear Pharmacy, V7
  32. Speziali MG, 2020, QUIM NOVA, V43, P1538, DOI 10.21577/0100-4042.20170620
  33. Speziali MG, 2012, QUIM NOVA, V35, P1700, DOI 10.1590/S0100-40422012000800035
  34. Toledo Patricia Tavares Magalhães de, 2011, J. Braz. Chem. Soc., V22, P1005, DOI 10.1590/S0103-50532011000600001
  35. Wang B, 2015, WORLD PAT INF, V40, P10, DOI 10.1016/j.wpi.2014.12.002
  36. WORLD HEALTH ORGANIZATION (WHO), 2021, Cancer de mama agora forma mais comum de cancer: OMS tomando medidas
  37. ZAPAROLLI D., 2021, Pesquisa FAPESP, V309, P66

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR